An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
SAN DIEGO--(BUSINESS WIRE)--
Cue Health Inc. (“Cue”) (Nasdaq: HLTH), a healthcare technology company, announced today that it will release its second quarter 2022 financial results on Wednesday, August 10, 2022. In conjunction with the release, Cue will host a conference call and webcast that day at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results and recent highlights.
To access the live call via telephone, please register in advance using the link here. Upon registering, each participant will receive an email confirmation with dial-in numbers and a unique personal PIN that can be used to join the call.
The live webinar of the call may be accessed by visiting the Events section of the Company’s website at investors.cuehealth.com. A replay of the webinar will be available on the Company’s website shortly after the conclusion of the call.
About Cue Health Cue is a healthcare technology company that makes it easy for individuals to access health information and places diagnostic information at the center of care. Cue enables people to manage their health through real-time, actionable, and connected health information, offering individuals and their healthcare providers easy access to lab-quality diagnostics anywhere, anytime, in a device that fits in the palm of the hand. Cue’s first-of-its-kind COVID-19 test was the first FDA-authorized molecular diagnostic test for at-home and over-the-counter use without a prescription and physician supervision. Outside the United States, Cue has received the CE mark in the European Union, Interim Order authorization from Health Canada, regulatory approval from India'sCentral Drugs Standard Control Organization, and PSAR authorization from Singapore'sHealth Sciences Authority. Cue was founded in 2010 and is headquartered in San Diego. For more information, please visit www.cuehealth.com.
cue, a revolutionary device for tracking health information at the molecular level. for the first time, consumers can track 5 key health and lifestyle indicators: inflammation, vitamin d, fertility, influenza, and testosterone in just minutes, at home. cue sends the data via bluetooth 4.0 to the user's smartphone, where the free cue app reveals the interplay of activity, food, and sleep shaping the user at a molecular level. by simply adding a noninvasive droplet of saliva, blood, or nasal swab, you can access deep information about your body only previously available from a lab -- on demand and on your schedule. interactive charts put you in touch with your health, making it easy to discover new trends, monitor your progress, and share it with the people who matter most. cue also features life feed, an incredible new smartphone-based way to visualize the daily effect of activity, food, and sleep on your molecular health. cue makes research-based recommendations for foods proven to sup
